Gynesonics is a Biotech company based in Redwood City, California. It has raised $338M in total funding. Latest round: Series F.
Gynesonics funding overview
Gynesonics is a Biotech company based in Redwood City, California. Gynesonics has raised $338M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series F announced in November 2023. The round record for Gynesonics runs through 2023; nothing later has been disclosed. Investors on record include Bain Capital Life Sciences, Endeavour Vision, Kaiser Permanente Ventures, Runway Growth Capital, Amzak Health, Abingworth. 6 distinct backers are named across the disclosed rounds.
Gynesonics at a glance
Total raised
$338M
Latest round
Series F
Latest round date
November 2023
Industry
Biotech
Headquarters
Redwood City, California
Notable investors
Bain Capital Life Sciences, Endeavour Vision, Kaiser Permanente Ventures, Runway Growth Capital, Amzak Health, Abingworth
Frequently asked about Gynesonics funding
How much has Gynesonics raised?
Gynesonics has raised $338M in total disclosed funding across the rounds on record.
Who has invested in Gynesonics?
Bain Capital Life Sciences, Endeavour Vision, Kaiser Permanente Ventures, Runway Growth Capital, Amzak Health, Abingworth are named among the investors backing Gynesonics.
What was the latest Gynesonics funding round?
The most recent disclosed round is a Series F, announced in November 2023.
Where is Gynesonics based?
Gynesonics is based in Redwood City, California.
What sector does Gynesonics operate in?
Gynesonics is tracked under Biotech from Redwood City, California, with $338M in disclosed funding.
When did Gynesonics last raise?
The last disclosed Gynesonics round closed in November 2023 at Series F.
We update the Gynesonics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Redwood City and their backers are listed below.
